BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22778788)

  • 1. Overutilization of proton-pump inhibitors: what the clinician needs to know.
    Heidelbaugh JJ; Kim AH; Chang R; Walker PC
    Therap Adv Gastroenterol; 2012 Jul; 5(4):219-32. PubMed ID: 22778788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.
    Heidelbaugh JJ
    Ther Adv Drug Saf; 2013 Jun; 4(3):125-33. PubMed ID: 25083257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S27-32. PubMed ID: 19262544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the long-term use of proton pump inhibitors.
    Thomson AB; Sauve MD; Kassam N; Kamitakahara H
    World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse events associated with long-term use of proton pump inhibitors].
    Reimer C; Bytzer P
    Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton Pump Inhibitors: Review of Emerging Concerns.
    Nehra AK; Alexander JA; Loftus CG; Nehra V
    Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Risks Associated With Proton Pump Inhibitors: A Systematic Review.
    Heidelbaugh JJ; Goldberg KL; Inadomi JM
    Gastroenterol Hepatol (N Y); 2009 Oct; 5(10):725-734. PubMed ID: 37967443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overuse of proton pump inhibitors.
    Ksiądzyna D; Szeląg A; Paradowski L
    Pol Arch Med Wewn; 2015; 125(4):289-98. PubMed ID: 25790817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?
    Fohl AL; Regal RE
    World J Gastrointest Pharmacol Ther; 2011 Jun; 2(3):17-26. PubMed ID: 21731913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems Associated with Deprescribing of Proton Pump Inhibitors.
    Helgadottir H; Bjornsson ES
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
    Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
    Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
    J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.